Literature DB >> 15272106

Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome.

Elspeth Guthrie1, Jo Barlow, Lakshmi Fernandes, Joy Ratcliffe, Nicholas Read, David G Thompson, Barbara Tomenson, Francis Creed.   

Abstract

OBJECTIVE: Reduced tolerance to rectal distension has been regarded as a biological marker for irritable bowel syndrome (IBS), but longitudinal studies are few. This study determined whether change in tolerance to rectal distension after psychological treatments was associated with: 1) change in abdominal pain; 2) change in psychological symptoms; 3) a reported history of sexual abuse.
METHODS: Participants completed a visual analogue scale of abdominal pain, SCL-90 and Hamilton rating scale of depression; discomfort threshold to rectal distension was determined using a double random staircase protocol. These were measured at entry to a trial of psychotherapy or paroxetine (selective serotonin reuptake inhibitor antidepressant) and 3 months later (N = 52). Analysis of change scores were adjusted for treatment group and baseline values.
RESULTS: Increased tolerance to distension after treatment was associated with reduction in depression (r = -0.37, p =.008) but not abdominal pain. Patients who reported prior sexual abuse showed greater increase in tolerance than the remainder (changes in volume threshold: -24.7 ml [SEM = 12.1] vs. 3.6 ml [SEM = 6.2], adjusted p =.045; changes in pressure threshold: -4.7 [SEM = 1.7] mm Hg vs. 0.96 [SEM=0.9], adjusted p =.005). Multiple regression indicated that reduction in depression score and a reported history of sexual abuse were independently associated with improved tolerance to distension.
CONCLUSIONS: In patients with severe IBS, increased tolerance to rectal distension after psychological treatment is significantly associated with improved depression and reported sexual abuse. These results suggest that in some patients with severe IBS psychological rather than biological processes are primarily responsible for reduced tolerance to rectal distension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15272106     DOI: 10.1097/01.psy.0000128899.22514.c0

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  18 in total

Review 1.  How do SSRIs help patients with irritable bowel syndrome?

Authors:  F Creed
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

2.  Should general psychiatry ignore somatization and hypochondriasis?

Authors:  Francis Creed
Journal:  World Psychiatry       Date:  2006-10       Impact factor: 49.548

3.  Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome.

Authors:  Mats B O Larsson; Kirsten Tillisch; A D Craig; Maria Engström; Jennifer Labus; Bruce Naliboff; Peter Lundberg; Magnus Ström; Emeran A Mayer; Susanna A Walter
Journal:  Gastroenterology       Date:  2011-11-19       Impact factor: 22.682

Review 4.  Irritable bowel syndrome: recent and novel therapeutic approaches.

Authors:  Viola Andresen; Michael Camilleri
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.

Authors:  Razieh Choghakhori; Amir Abbasnezhad; Reza Amani; Meysam Alipour
Journal:  Dig Dis Sci       Date:  2017-04-03       Impact factor: 3.199

6.  Anxiety, depression and quality of life in patients with irritable bowel syndrome.

Authors:  Hyun Sun Cho; Jae Myung Park; Chul Hyun Lim; Yu Kyung Cho; In Seok Lee; Sang Woo Kim; Myung-Gyu Choi; In-Sik Chung; Yun Kyung Chung
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

7.  Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity.

Authors:  Spencer D Dorn; Olafur S Palsson; Syed I M Thiwan; Motoyori Kanazawa; W Crawford Clark; Miranda A L van Tilburg; Douglas A Drossman; Yolanda Scarlett; Rona L Levy; Yehuda Ringel; Michael D Crowell; Kevin W Olden; William E Whitehead
Journal:  Gut       Date:  2007-05-04       Impact factor: 23.059

8.  The impact of irritable bowel syndrome on health-related quality of life: a Singapore perspective.

Authors:  Yu Tien Wang; Hwee Yong Lim; David Tai; Thinesh L Krishnamoorthy; Tira Tan; Sylvaine Barbier; Julian Thumboo
Journal:  BMC Gastroenterol       Date:  2012-08-09       Impact factor: 3.067

9.  Rectal visceral sensitivity in women with irritable bowel syndrome without psychiatric comorbidity compared with healthy volunteers.

Authors:  Signe Spetalen; Leiv Sandvik; Svein Blomhoff; Morten B Jacobsen
Journal:  Gastroenterol Res Pract       Date:  2009-09-17       Impact factor: 2.260

10.  Rectal hyposensitivity.

Authors:  Rebecca E Burgell; S Mark Scott
Journal:  J Neurogastroenterol Motil       Date:  2012-10-09       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.